Adult T-Cell Leukemia/Lymphoma

  • Amrita Goyal
  • Joi B. Carter
  • Lyn McDivitt DuncanEmail author


Adult T-cell leukemia/lymphoma (ATLL) is an aggressive peripheral T-cell lymphoma caused by long-term infection with human T-lymphotropic virus 1 (HTLV-1). Patients with ATLL have an extremely poor prognosis, their disease complicated by multidrug resistance of malignant cells, infection due to impaired T-cell mediated immunity, hypercalcemia, and multiple organ failure. Half of patients develop cutaneous manifestations. The cutaneous lesions of ATLL are highly varied and include erythroderma, purpuric papules, and plaques. This chapter addresses the clinical presentation, prognosis, treatment, histopathology, immunohistochemistry, and molecular characteristics of this disease. It closes with a differential diagnosis and clinical case.


Adult T-cell leukemia/lymphoma ATLL HTLV-1 Acute Lymphomatous Chronic Smoldering Hypercalcemia Opportunistic infection Cerebriform cells Mycosis fungoides Sézary Flower cells Viral synapse Breastfeeding Proviral integration 


  1. 1.
    Ohshima K, Jaffe ES, Kikuchi M. Adult T-cell leukaemia/lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2008. p. 281–4.Google Scholar
  2. 2.
    Ishitsuka K, Tamura K. Treatment of adult T-cell leukemia/lymphoma: past, present, and future. Eur J Haematol. 2008;80:185–96.PubMedCrossRefGoogle Scholar
  3. 3.
    Ishida T, Utsunomiya A, Iida S, Inagaki H, Takatsuka Y, Kusumoto S, et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res. 2003;9:3625–34.PubMedGoogle Scholar
  4. 4.
    Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50:481–92.PubMedGoogle Scholar
  5. 5.
    Swerdlow SH, Habeshaw JA, Rohatiner AZ, Lister TA, Stansfeld AG. Caribbean T-cell lymphoma/leukemia. Cancer. 1984;54:687–96.PubMedCrossRefGoogle Scholar
  6. 6.
    Matsuoka M, Jeang K-T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007;7:270–80.PubMedCrossRefGoogle Scholar
  7. 7.
    Taylor GP, Matsuoka M. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogene. 2005;24:6047–57.PubMedCrossRefGoogle Scholar
  8. 8.
    Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. Br J Haematol. 1991;79:428–37.PubMedCrossRefGoogle Scholar
  9. 9.
    Ohshima K. Pathological features of diseases associated with human T-cell leukemia virus type I. Cancer Sci. 2007;98:772–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Chan HL, Su IJ, Kuo TT, Kuan YZ, Chen MJ, Shih LY, et al. Cutaneous manifestations of adult T cell leukemia/lymphoma. Report of three different forms. J Am Acad Dermatol. 1985;13:213–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Yamaguchi T, Ohshima K, Karube K, Tutiya T, Kawano R, Suefuji H, et al. Clinicopathological features of cutaneous lesions of adult T-cell leukaemia/lymphoma. Br J Dermatol. 2005;152:76–81.PubMedCrossRefGoogle Scholar
  12. 12.
    Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol. 2009;27:453–9.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Matutes E. Adult T-cell leukaemia/lymphoma. J Clin Pathol. 2007;60:1373–7.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Bunn PA, Schechter GP, Jaffe ES, Blayney D, Young RC, Matthews MJ, et al. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med. 1983;309:257–64.PubMedCrossRefGoogle Scholar
  15. 15.
    Nakase K, Hara M, Kozuka T, Tanimoto K, Nawa Y. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma. Bone Marrow Transplant. 2006;37:41–4.PubMedGoogle Scholar
  16. 16.
    Hermine O, Bouscary D, Gessain A, Turlure P, Leblond V, Franck N, et al. Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med. 1995;332:1749–51.PubMedCrossRefGoogle Scholar
  17. 17.
    Karube K, Ohshima K, Tsuchiya T, Yamaguchi T, Kawano R, Suzumiya J, et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells. Br J Haematol. 2004;126:81–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Jaffe E, Cossman J, Blattner W, Robert-Guroff M, Blayney D, Gallo RC, et al. The pathologic spectrum of adult T-cell leukemia/lymphoma in the United States. Am J Surg Pathol. 1984;8:263–75.PubMedCrossRefGoogle Scholar
  19. 19.
    Kazakov DV, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol. 2004;18:397–415.PubMedCrossRefGoogle Scholar
  20. 20.
    Waldmann TA, Greene WC, Sarin PS, Saxinger C, Blayney DW, Blattner WA, et al. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor. J Clin Invest. 1984;73:1711–8.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Amrita Goyal
    • 1
  • Joi B. Carter
    • 2
  • Lyn McDivitt Duncan
    • 3
    Email author
  1. 1.Harvard-MIT Division of Health Sciences and TechnologyHarvard Medical SchoolBostonUSA
  2. 2.Department of DermatologyMassachusetts General Hospital, Harvard Medical SchoolBostonUSA
  3. 3.Dermatopathology Service, Department of PathologyMassachusetts General Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations